文献速递肝病

白细胞介素-18信号促进小鼠肝纤维化中肝星状细胞的活化

Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis.
PubMed 文献 · Hepatology · 2022-10-12

研究显示肝硬化患者血清IL-18(128.4 pg/ml vs. 74.9 pg/ml)和IL-18结合蛋白(46.50 ng/ml vs. 15.35 ng/ml)较健康对照显著升高,小鼠肝星状细胞高表达Il18与Il18r1,IL-18可加速其向肌成纤维细胞转分化,阻断IL-18信号可减轻纤维化。

要点

  • 肝硬化患者血清IL-18与IL-18结合蛋白水平高于健康对照。
  • 小鼠肝星状细胞高表达Il18与Il18r1,IL-18加速其转分化。
  • 阻断IL-18信号可减轻小鼠肝纤维化,IL-18为治疗靶点。

核心结论

  • IL-18通过直接作用于肝星状细胞活化促进肝纤维化发展,IL-18可作为治疗肝纤维化的靶点。

研究设计与样本

  • 研究纳入肝硬化患者与健康对照检测血清IL-18及IL-18结合蛋白水平,并采用小鼠肝纤维化模型、原代肝星状细胞培养及单细胞RNA测序进行分析。

主要发现

  • 肝硬化患者血清IL-18为128.4 pg/ml,健康对照为74.9 pg/ml;血清IL-18结合蛋白为46.50 ng/ml,健康对照为15.35 ng/ml。
  • 单细胞RNA测序显示小鼠肝星状细胞中一个免疫调节亚群高表达Il18和Il18r1。
  • 重组小鼠IL-18处理可加速培养的原代小鼠肝星状细胞向肌成纤维细胞转分化。
  • IL-18受体缺陷小鼠在肝星状细胞特异性NLRP3过度活化诱导的纤维化模型中肝纤维化减轻。
  • 喂食胆碱缺乏、L-氨基酸限定、高脂饮食10周的Il18-/-小鼠纤维化改变减轻,α平滑肌肌动蛋白阳性细胞数和胶原沉积减少。

关键数值与推荐

  • IL-18BP阻断IL-18信号后,NLRP3炎症小体激活触发的肝星状细胞活化被消除。
  • IL-18BP可逆转髓系细胞特异性NLRP3功能获得相关的严重炎症表型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Nucleotide-binding oligomerization domain-like receptor-family pyrin domain-containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis. Mechanisms and downstream signaling remain incompletely understood. Here, we studied the role of IL-18 in hepatic stellate cells (HSCs), and its impact on liver fibrosis. APPROACH AND RESULTS: We observed significantly increased serum levels of IL-18 (128.4 pg/ml vs. 74.9 pg/ml) and IL-18 binding protein (BP; 46.50 ng/ml vs. 15.35 ng/ml) in patients with liver cirrhosis compared with healthy controls. Single cell RNA sequencing data showed that an immunoregulatory subset of murine HSCs highly expresses Il18 and Il18r1 . Treatment of cultured primary murine HSC with recombinant mouse IL-18 accelerated their transdifferentiation into myofibroblasts. In vivo , IL-18 receptor-deficient mice had reduced liver fibrosis in a model of fibrosis induced by HSC-specific NLRP3 overactivation. Whole liver RNA sequencing analysis from a murine model of severe NASH-induced fibrosis by feeding a choline-deficient, L-amino acid-defined, high fat diet showed that genes related to IL-18 and its downstream signaling were significantly upregulated, and Il18-/- mice receiving this diet for 10 weeks showed protection from fibrotic changes with decreased number of alpha smooth muscle actin-positive cells and collagen deposition. HSC activation triggered by NLRP3 inflammasome activation was abrogated when IL-18 signaling was blocked by its naturally occurring antagonist IL-18BP. Accordingly, we observed that the severe inflammatory phenotype associated with myeloid cell-specific NLRP3 gain-of-function was rescued by IL-18BP. CONCLUSIONS: Our study highlights the role of IL-18 in the development of liver fibrosis by its direct effect on HSC activation identifying IL-18 as a target to treat liver fibrosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Knorr J, Kaufmann B, Inzaugarat ME, et al. Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology. 2022. PMID: 36059147. doi:10.1002/hep.32776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。